Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 2 Propranolol 2 talimogene laherparepvec 1 sargramostim 1 romiplostim 1 propranolol CR 1 imisopasem manganese 1 dabrafenib 1 cobimetinib 1 aldesleukin 1 Vemurafenib 1 Vaccines 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Paclitaxel 1 Nivolumab 1 Nanoparticles 1 Ketones 1 Interleukin-2 1 Glucose 1 Diet Therapy 1 CA-4948 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Melanoma × romiplostim × Clear all

NCT04427306 2023-09-15

Neoadjuvant T-VEC in High Risk Early Melanoma

University of California, Davis

Phase 2 Suspended

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡